Thursday, January 19, 2012

Lyme disease update

It has been three decades since the agent of Lyme disease, the spirochete Borrelia burgdorferi, and the ticks that vector it were identified. However, the number of Lyme disease cases have steadily increased. An article in the Journal of Medical Entomology assessed the potential reasons for the continued lack of success in prevention and control of Lyme disease.
  1. Identifying critical host infestation rates required to maintain transmission of B. burgdorferi
  2. Understanding how habitat diversity and forest fragmentation impacts risk of exposure
  3. Refining knowledge of how human behavior influences Lyme disease risk and identifying barriers to the adoption of personal protective measures and environmental tick management.
  4. They are difficult to isolate, grow, and study in the lab.
  5. There are five subspecies of Bb, over 100 strains in the US, and 300 strains worldwide. This diversity is thought to contribute to its ability to evade the immune system.
The disease affects every tissue and every major organ system in the body. Clinically, it can appear as a chronic arthalgia (joint pain), fibromyalgia (fibrous connective tissue and muscle pain), chronic fatigue, brain fog, immune dysfunction, and neurological disease. Standard medical treatment usually involves antibiotics. In some patients, Lyme disease can be fairly easy to treat, while in others, it can feel like a never-ending battle. One reason treatment is difficult is because Bb has an in vitro replication cycle of about seven days, one of the longest of any known bacteria. Antibiotics are most effective during bacterial replication, so the more cycles during a treatment, the better. Standard antibiotic treatment to treat Lyme disease may last thirty weeks. In addition, there are frequently co-infections—other tick-transmitted diseases—that come along for the ride.

Many physicians continue to deny the existence of Chronic Lyme Disease, which can hinder efforts to find a solution—and without consensus from mainstream Western medicine, insurance companies will rarely provide treatment, and disability coverage is routinely denied. On the other hand, more physicians are finding it convenient to label a patient with Lyme Disease if they have exhausted all other possibilities, even without a confirmed diagnosis.

One big problem is that most doctors follow a standard (but arbitrary) two-tier diagnostic protocol, requiring both a positive ELISA and Western Blot test. But despite the fact that this approach fails to detect up to 90% of cases and does not distinguish between acute, chronic, or resolved infection, these criteria have been used as rigid diagnostic benchmarks that have prevented individuals with Lyme disease from obtaining treatment.

One hopeful area of research looks at live cultures under a fluorescent microscope, and measures the live organisms in the bloodstream, so one can keep retesting to see which therapies are working and which aren’t. This is a critical difference. An antibody test only shows whether you have been exposed to the illness. A live organism test shows whether you are recovering or have recovered.

There are a great many alternative therapies being used to treat Lyme disease because there is no definitive cure. Besides antibiotics, many physicians prescribe a program of vitamins, nutritional supplements, herbs, and antiviral and antibacterial nutraceuticals. Hyperbaric oxygen therapy has offered significant alleviation of symptoms, and intravenous vitamin C may prove successful. Traditional Chinese Medicine protocols (Chinese herbs, acupuncture, etc.) frequently achieve positive results—they are generally the same for Lyme disease as for Chronic Fatigue Syndrome and fibromyalgia, since their symptoms so frequently overlap.

No comments:

Post a Comment